{"skill":{"slug":"regeneron","displayName":"Regeneron","summary":"全球领先生物技术制药公司，核心产品Eylea和Dupixent年销售超200亿美元，专注基因工程和抗体开发。","tags":{"latest":"1.0.0"},"stats":{"comments":0,"downloads":79,"installsAllTime":0,"installsCurrent":0,"stars":0,"versions":1},"createdAt":1776842598372,"updatedAt":1776843713204},"latestVersion":{"version":"1.0.0","createdAt":1776842598372,"changelog":"Regeneron skill v1.0.0 changelog\n\n- 提供再生元制药（Regeneron）公司详细介绍及历史发展里程碑\n- 解析公司核心业务、主要产品（Eylea、Dupixent）及市场地位\n- 展示VelocImmune等技术平台和与赛诺菲的战略合作优势\n- 汇总关键财务与业务数据，概述研发管线和市场份额\n- 增补值得了解的趣味/行业见解，方便投资分析及竞品对比","license":"MIT-0"},"metadata":null,"owner":{"handle":"hanxueyuan","userId":"s17eht14r6y7ztwaw37n96ka7583eghn","displayName":"hanxueyuan","image":"https://avatars.githubusercontent.com/u/16717383?v=4"},"moderation":null}